Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Zydus Lifesciences Ltd (ZYDU)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
948.00 -3.25    -0.34%
26/04 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE010B01027 
S/N:  ZYDUSLIFE
  • Volume: 697,084
  • Bid/Ask: 947.85 / 948.00
  • Day's Range: 944.50 - 958.65
Zydus Lifesciences 948.00 -3.25 -0.34%

Zydus Lifesciences Ltd Company Profile

 
Get an in-depth profile of Zydus Lifesciences Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

23000

Equity Type

ORD

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company offers the products under the Everyuth and Nutralite, Complan, Glucon D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India.

Contact Information

Address Zydus Corporate Park Scheme No. 63
Survey No. 536, Khoraj (Gandhinagar) Nr. Vaishnodevi Circle, S. G. Highway Ahmedabad,382481
India
Phone 91 79 7180 0000
Fax 91 79 2686 8337

Top Executives

Name Age Since Title
Dharmishtaben Narendraprasad Raval 65 2014 Non-Executive Independent Director
Sharvil Pankajbhai Patel 42 1997 MD & Executive Director
Pankaj Ramanbhai Patel 68 1995 Non-Executive Chairman
Apurva S. Diwanji 52 2016 Independent Director
Nitin Raojibhai Desai 76 2011 Non-Executive Independent Director
Ganesh Narayan Nayak 66 2017 COO & Executive Director
Mukeshbhai Mangalbhai Patel 68 1997 Non-Executive Non-Independent Director
Bhadresh Kantilal Shah 71 2018 Independent Director
Upasana Kamineni Konidela - 2022 Independent Director
Akhil Monappa - 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ZYDU Comments

Write your thoughts about Zydus Lifesciences Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
invest market
INVEST2MARKETS Sep 20, 2023 12:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update ZYDUSLIFE Revised Stop Loss 637 from 624
invest market
INVEST2MARKETS Sep 18, 2023 2:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update ZYDUSLIFE from 640 from 624
invest market
INVEST2MARKETS Sep 13, 2023 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Delivery Buy ZYDUSLIFE above 647 Stop Loss 624 Target 670+
Tushar Parekh
Tushar Parekh Jun 15, 2023 2:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell he will down again 520
Amit Sonker
Amit Sonker Oct 03, 2022 2:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next target 425-450 🎯
Muthu Pandi
Muthu Pandi Aug 12, 2022 3:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next target 350
Mahadev Padhy
Mahadev Padhy May 20, 2022 3:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very nice results
Vinod Mahalle
Vinod Mahalle May 04, 2022 6:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
loose drastically
Mahesh Jamadar
Mahesh Jamadar Feb 01, 2022 1:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next target would be 435
Mahesh Jamadar
Mahesh Jamadar Feb 01, 2022 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
164374044663605.jpg
Tomorrow make/break
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email